All states
- 8Medicaid covers GLP-1s for obesity
- 2Medicaid covers with limits
- 16State employee plan covers
- 5States with specific compounding rules we list
| State | Medicaid (obesity) | State employee plan | Adult obesity (CDC) | State rules | Programs serving |
|---|---|---|---|---|---|
| Alabama | not covered kff.org | not found | 39.7% 2025 | Alabama Board of Pharmacy (relayed by the medical board): compounding with semaglutide salts, non-pharmaceutical-grade ingredients, or ingredients not made by an FDA-registered facility is prohibited; a 2024 medical board ruling bars physicians from compounding GLP-1s with non-prescription-grade ingredients. Several online programs exclude Alabama. albme.gov | 7 |
| Alaska | not covered kff.org | covered intranet.akleg.gov | 33% 2025 | — | 8 |
| Arizona | not covered kff.org | not found | 32.3% 2025 | — | 8 |
| Arkansas | not covered kff.org | not covered sas.arkansas.gov | 36.7% 2025 | — | 8 |
| California | not covered medi-calrx.dhcs.ca.gov | not found | 29.1% 2024 | — | 8 |
| Colorado | not covered kff.org | covered dhr.colorado.gov | 25.7% 2025 | — | 8 |
| Connecticut | not covered kff.org | covered carecompass.ct.gov | 30.4% 2025 | — | 8 |
| Delaware | covered medicaidpublications.dhss.delaware.gov | covered dhr.delaware.gov | 36.3% 2025 | — | 8 |
| District of Columbia | not covered kff.org | not found | 24.2% 2025 | — | 0 |
| Florida | not covered kff.org | limited mybenefits.myflorida.com | 30% 2025 | — | 8 |
| Georgia | not covered kff.org | covered shbp.georgia.gov | 35.9% 2025 | — | 8 |
| Hawaii | not covered kff.org | covered eutf.hawaii.gov | 26.4% 2025 | — | 8 |
| Idaho | not covered kff.org | not covered ogi.idaho.gov | 32.6% 2025 | — | 8 |
| Illinois | not covered kff.org | covered cms.illinois.gov | 33.7% 2025 | — | 8 |
| Indiana | not covered kff.org | not covered in.gov | 37.5% 2025 | Indiana SB 282 (signed 2026, effective July 1, 2026) tightens compounding from bulk drug substances (pharmaceutical-grade, federal-law compliance, Board of Pharmacy enforcement) and requires medical spas that dispense weight-loss drugs to register by Jan 1, 2027. iga.in.gov | 8 |
| Iowa | not covered kff.org | not found | 36.9% 2025 | — | 8 |
| Kansas | covered kdhe.ks.gov | covered sehp.healthbenefitsprogram.ks.gov | 37.3% 2025 | — | 8 |
| Kentucky | not covered kff.org | covered extranet.personnel.ky.gov | 38.8% 2025 | — | 8 |
| Louisiana | not covered kff.org | not covered web.archive.org | 35.6% 2025 | In August 2023 the Louisiana Board of Pharmacy fined a Baton Rouge pharmacy for dispensing semaglutide sodium. Several online programs exclude Louisiana. nabp.pharmacy | 5 |
| Maine | not covered kff.org | covered maine.gov | 33% 2025 | — | 8 |
| Maryland | not covered kff.org | not covered dbm.maryland.gov | 33.1% 2025 | — | 8 |
| Massachusetts | not covered mass.gov | not covered mass.gov | 27% 2025 | — | 8 |
| Michigan | limited priorityhealth.com | not covered michigan.gov | 35.1% 2025 | — | 8 |
| Minnesota | covered mn.gov | covered mn.gov | 33.1% 2025 | — | 8 |
| Mississippi | covered medicaid.ms.gov | not covered dfa.ms.gov | 40.4% 2024 | Mississippi medical board rule 2640-1.5(F) bars prescribing a legend drug for weight loss unless it has an FDA-approved indication for that purpose, so compounded semaglutide or tirzepatide for weight loss alone is off-limits unless the board grants a waiver. Several online programs exclude Mississippi. law.cornell.edu | 5 |
| Missouri | covered dss.mo.gov | not found | 36.6% 2025 | — | 8 |
| Montana | not covered kff.org | not covered doa.mt.gov | 30.3% 2025 | — | 8 |
| Nebraska | not covered kff.org | not covered web.archive.org | 36% 2025 | — | 8 |
| Nevada | not covered kff.org | not covered pebp.nv.gov | 34.2% 2024 | — | 8 |
| New Hampshire | not covered nh.primetherapeutics.com | not found | 31.6% 2025 | — | 8 |
| New Jersey | not covered kff.org | covered nj.gov | 27% 2025 | — | 8 |
| New Mexico | not covered kff.org | not found | 35.3% 2025 | — | 8 |
| New York | not covered kff.org | covered cs.ny.gov | 28.5% 2025 | — | 8 |
| North Carolina | covered medicaid.ncdhhs.gov | not covered wral.com | 33.5% 2025 | — | 8 |
| North Dakota | not covered kff.org | not covered ndpers.nd.gov | 39.1% 2025 | — | 8 |
| Ohio | not covered kff.org | not covered das.ohio.gov | 36% 2025 | — | 8 |
| Oklahoma | not covered kff.org | not found | 38.1% 2025 | — | 8 |
| Oregon | not covered kff.org | not covered oregon.gov | 32.7% 2025 | Oregon Board of Pharmacy position statement (v. 2/2025): compounded GLP-1s must use pharmaceutical-grade ingredients from FDA-registered sources, no semaglutide salt forms, and a lower price alone does not justify compounding a copy of a commercial drug. oregon.gov | 8 |
| Pennsylvania | not covered pa.gov | not found | 33.5% 2025 | — | 8 |
| Rhode Island | not covered eohhs.ri.gov | not covered employeebenefits.ri.gov | 31.3% 2025 | — | 8 |
| South Carolina | not covered kff.org | not covered peba.sc.gov | 36.5% 2025 | — | 8 |
| South Dakota | not covered kff.org | not found | 34.3% 2025 | — | 8 |
| Tennessee | covered contenthub-aem.optumrx.com | covered tn.gov | 37.9% 2025 | — | 8 |
| Texas | not covered kff.org | not covered express-scripts.com | 36.1% 2025 | — | 8 |
| Utah | not covered medicaid-documents.dhhs.utah.gov | limited pehp.org | 29.8% 2025 | — | 8 |
| Vermont | not covered kff.org | not found | 29.1% 2025 | — | 8 |
| Virginia | limited virginiamedicaidpharmacyservices.com | covered sfac.virginia.gov | 34.2% 2025 | — | 8 |
| Washington | not covered kff.org | not found | 31% 2025 | — | 8 |
| West Virginia | not covered kff.org | not covered peia.wv.gov | 37.4% 2025 | — | 8 |
| Wisconsin | covered forwardhealth.wi.gov | not covered etf.wi.gov | 36.6% 2025 | — | 8 |
| Wyoming | not covered kff.org | covered ai.wyo.gov | 32.6% 2025 | — | 8 |
"Programs serving" counts the online programs we compare that say on their own site that they serve the state; programs whose state list we could not confirm are not counted. "Not found" means we found no state employee plan policy to cite, not that the plan excludes GLP-1s.
Download the data
All 51 rows as a CSV file, with the source link for every row.
Cite this
Free to quote and link with credit to telehealth.help and a link to this page (CC BY 4.0).
telehealth.help. "GLP-1 coverage and access by US state." Updated November 8, 2026. https://telehealth.help/data/states doi:10.5281/zenodo.24053467Archived copy with a DOI: doi.org/10.5281/zenodo.24053467
Paying without coverage? Compare online programs
Prescribed online by US-licensed clinicians. Check that a program serves your state before you sign up.
How we picked
Every program here is prescribed online by a US-licensed clinician, fills prescriptions through a licensed US pharmacy and lets you start without an office visit. Each card shows the price we read on the program's own site (or says when a program prices only after its intake) and what that price covers, and we keep the date of every read; some programs bill a membership and the medication separately, and the card says so. The label on each card says what that program stands out for. How we check prices and programs.
- Daily oral plan#1
Intro offer: from $7 a dayA daily oral GLP-1 plan. No needles, no injections
- Compounded oral GLP-1 from $7 a day, prescribed online
- Free next-day delivery and weekly 3D body scans in the app
- HSA/FSA accepted; available in every state but LA and MS
GLP-1 protocol from$199/moon the 3-month plan with the $100 welcome credit ($299 without), shipped monthly; the home page names no form for this plan (the oral offer is from $7 a day)Visit HumeCare Read our HumeCare review - Money-back guarantee#2
48% off your first monthLose weight or get your money back
- Medication refund if you lose under 20% in 6 months (program rules apply)
- Licensed clinician review in about 24 hours
- Health coach, free dietitian consult and 24/7 care team
First month from$129/mosemaglutide welcome offer; tirzepatide from $169Visit LevelsRx Read our LevelsRx review - Pills or shots#3
Semaglutide from $99/moChoose weekly shots or daily tablets; shots from $99/mo on the 12-month plan
- Compounded semaglutide or tirzepatide, injection or tablet
- Medication, provider, supplies and free overnight shipping included
- Provider review in about 24 hours, all 50 states, no membership fee
Semaglutide shots from$99/moon the 12-month plan; $199 month to monthVisit BetterMe Rx Read our BetterMe Rx review